Canada Markets open in 2 hrs 23 mins

Grifols, S.A. (GIFLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
10.330.00 (0.00%)
At close: 10:58AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close10.33
Open10.33
Bid0.00 x 0
Ask0.00 x 0
Day's Range10.33 - 10.33
52 Week Range7.90 - 21.00
Volume2,440
Avg. Volume2,036
Market Cap5.967B
Beta (5Y Monthly)0.33
PE Ratio (TTM)9.52
EPS (TTM)1.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 03, 2021
1y Target EstN/A
  • Reuters

    Spanish pharmaceuticals firm Grifols reports 30% drop in nine-month profit

    Spanish pharmaceutical company Grifols reported a 30% drop in nine-month net profit on Tuesday, due in part to acquisition costs. Grifols said it was still on track to meet its full-year financial targets, but its shares fell 4.2% in morning trade. The company, which uses blood plasma to make medicines, saw its business severely hit by the pandemic as blood collection was halted in many countries.

  • Reuters

    Grifols says U.S. blood donors' lawsuit won't have material impact, shares down

    Spanish pharma group Grifols said on Friday a lawsuit filed in the United States by blood donors who claim the company violated their privacy would have no material impact, after a report in newspaper El Economista sent the shares sharply lower. The company said about 54,000 donors in Illinois had filed a lawsuit claiming Grifols breached data protection regulations, confirming the newspaper report. Grifols shares were down 5.3% on Friday morning, briefly the worst performer on the blue-chip Ibex-35 index, which was down 2.1%.

  • Reuters

    Grifols appoints executive chairman as seeks to speed recovery

    Grifols appointed an executive chairman on Monday, as the Spanish pharmaceutical company strives to recover from a pandemic-related hit and a 49% drop in its shares so far this year. Steven F. Mayer, an independent board member since 2011 and a former senior managing director of Cerberus Global Private Equity, will become executive chairman, effective immediately. The company's outgoing non-executive chairman, Victor Grifols Roura, who was chief executive from 1987 to 2016, has been named honorary chairman.